Skip to content
Trial Eligibility
Menu

A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

NCT05164172

This study is recruiting at 14 US sites in 10 states, according to its ClinicalTrials.gov record last updated .

Summary

The main goal of the study is to assess the long-term safety of eptinezumab on children and adolescents ages 6 to 17 with chronic or episodic migraine.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Migraine

Eligibility basics and study details

Study type
Interventional
Phase
Phase 3
Ages
6 to 17 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
H. Lundbeck A/S
Last updated on ClinicalTrials.gov
October 14, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Connecticut · 2

  • Yale School of Medicine - The Scirex Clinical Research Unit · New Haven, CT
  • New England Institute for Clinical Research (NEICR) - Stamford · Stamford, CT

Florida · 3

  • NW FL Clinical Research Group, LLC · Gulf Breeze, FL
  • AGA Clinical Trials · Hialeah, FL
  • University of South Florida (USF) - Tampa Campus · Tampa, FL

Kentucky · 1

  • University of Kentucky (UK) - Markey Cancer Center · Lexington, KY

Maryland · 1

  • University of Maryland School of Medicine · Baltimore, MD

New York · 1

  • True North Neurology - Commack (North Suffolk Neurology) · Commack, NY

Ohio · 2

  • Akron Children's Hospital · Akron, OH
  • Cincinnati Children's Hospital Medical Center-Burnet Campus · Cincinnati, OH

Texas · 1

  • Road Runner Research (RRR) · San Antonio, TX

Virginia · 1

  • Children's Specialty Group (CSG) · Norfolk, VA

West Virginia · 1

  • Marshall Health-Marshall University Medical Center · Huntington, WV

Wisconsin · 1

  • Children's Wisconsin (Children's Hospital of Wisconsin)-Main Campus · Milwaukee, WI

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.